These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36792176)

  • 21. Effects of growth hormone therapy on cardiac dimensions in children and adolescents with Prader-Willi syndrome.
    Hauffa BP; Knaup K; Lehmann N; Neudorf U; Nagel B
    Horm Res Paediatr; 2011; 75(1):56-62. PubMed ID: 20924154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment.
    Festen DA; de Weerd AW; van den Bossche RA; Joosten K; Hoeve H; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4911-5. PubMed ID: 17003096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome.
    Miller J; Silverstein J; Shuster J; Driscoll DJ; Wagner M
    J Clin Endocrinol Metab; 2006 Feb; 91(2):413-7. PubMed ID: 16317059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visceral adipose tissue increases shortly after the cessation of GH therapy in adults with Prader-Willi syndrome.
    Koizumi M; Ida S; Shoji Y; Nishimoto Y; Etani Y; Kawai M
    Endocr J; 2018 Nov; 65(11):1127-1137. PubMed ID: 30185718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory markers in adults with Prader-Willi syndrome before and during 12 months growth hormone treatment.
    Höybye C
    Horm Res; 2006; 66(1):27-32. PubMed ID: 16685133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth Charts for Prader-Willi Syndrome During Growth Hormone Treatment.
    Butler MG; Lee J; Cox DM; Manzardo AM; Gold JA; Miller JL; Roof E; Dykens E; Kimonis V; Driscoll DJ
    Clin Pediatr (Phila); 2016 Sep; 55(10):957-74. PubMed ID: 26842920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome.
    Sode-Carlsen R; Farholt S; Rabben KF; Bollerslev J; Schreiner T; Jurik AG; Frystyk J; Christiansen JS; Höybye C
    Growth Horm IGF Res; 2011 Aug; 21(4):185-90. PubMed ID: 21664161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What endocrinologists can do to prevent cardiovascular complications in adults with Prader-Willi syndrome: Lessons from a case series.
    Pellikaan K; van Weijen PMH; Rosenberg AGW; Hoekstra FME; Vermaak M; Oomen PHN; van der Lely AJ; Cuypers JAAE; de Graaff LCG
    Front Endocrinol (Lausanne); 2023; 14():1145066. PubMed ID: 37033248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prader-Willi syndrome].
    Heiberg A; Lofterød B
    Nord Med; 1991; 106(6-7):189-90. PubMed ID: 1852594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone therapy for children and adolescents with Prader-Willi syndrome is associated with improved body composition and metabolic status in adulthood.
    Coupaye M; Lorenzini F; Lloret-Linares C; Molinas C; Pinto G; Diene G; Mimoun E; Demeer G; Labrousse F; Jauregi J; Laurier V; Basdevant A; Polak M; Thuilleaux D; Tauber M; Poitou C
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E328-35. PubMed ID: 23284006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Extreme obesity in Prader-Willi Syndrome (PWS)].
    Damiano J; Ficko C; Garrabé E; Mayaudon H; Dupuy O; Carmoi T; Bordier L; Bauduceau B
    Rev Med Interne; 2003 Sep; 24(9):617-20. PubMed ID: 12951183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Care continuity for patients with Prader-Willi syndrome during transition from childhood to adulthood].
    Saitoh S
    Nihon Rinsho; 2010 Jan; 68(1):141-4. PubMed ID: 20077807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulated GH levels during the transition phase in Prader-Willi syndrome.
    Grugni G; Marzullo P; Delvecchio M; Iughetti L; Licenziati MR; Osimani S; Ragusa L; Salvatoni A; Sartorio A; Stagi S; Crinò A;
    J Endocrinol Invest; 2021 Jul; 44(7):1465-1474. PubMed ID: 33095904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes Mellitus in Prader-Willi Syndrome: Natural History during the Transition from Childhood to Adulthood in a Cohort of 39 Patients.
    Clerc A; Coupaye M; Mosbah H; Pinto G; Laurier V; Mourre F; Merrien C; Diene G; Poitou C; Tauber M
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience.
    Yang A; Kim J; Cho SY; Jin DK
    Orphanet J Rare Dis; 2017 Aug; 12(1):146. PubMed ID: 28854950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Prader-Willi Syndrome (PWS) in adults - what an endocrinologist needs to know. Recommendations of the Polish Society of Endocrinology and the Polish Society of Paediatric Endocrinology and Diabetology.
    Góralska M; Bednarczuk T; Rosłon M; Libura M; Szalecki M; Hilczer M; Stawerska R; Smyczyńska J; Karbownik-Lewińska M; Walczak M; Lewiński A
    Endokrynol Pol; 2018; 69(4):. PubMed ID: 30209801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three years of growth hormone treatment in young adults with Prader-Willi Syndrome previously treated with growth hormone in childhood: Effects on glucose homeostasis and metabolic syndrome.
    Damen L; Grootjen LN; Donze SH; Juriaans AF; de Graaff LCG; van der Velden JAEM; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):439-448. PubMed ID: 32609902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone treatment of Prader-Willi syndrome has long-term, positive effects on body composition.
    Höybye C
    Acta Paediatr; 2015 Apr; 104(4):422-7. PubMed ID: 25557351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.